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1 Introduction
Premature rupture of the membranes in preg-
nancy normally implies a considerable risk for
mother and fetus. For example, for each 4,500
deliveries after premature rupture of the mem-
branes, one maternal death must be expected
[22]. For the total birth rate, due to premature
rupture of the membranes and the resulting
complications 1 maternal death should be ex-
pected for each 20,000 deliveries [3]. When ad-
equate antibiotic protection is provided [16], in
case of premature rupture of the membranes,
pyrexia is probably not greater than in deliver-
ies after rupture of the membranes at term.
Although the child is jeopardized by prolapse
of the cord and amniotic infection syndrome
(AIS), the primary jeopardy is with premature
birth and its resulting consequences. Perinatal
mortality is 2 to 3 times higher than normal
and predominantly affects neonates whose
birth weight is less than 2,500 g [16].
The incidence of neurologic complications in
preterm infants is directly proportional to the
interval between rupture of the membranes and
parturition [13]. Until recently one could not
determine whether the development of RDS
in preterm infants born after rupture of the
membranes is either increased or decreased [4,
14, 19, 20, 24].
The methods of preventing premature rupture
of the membranes are rather limited. In the
case of cervical insufficiency one of these is
cerclage performed at the appropriate time.
Until recently there was no effective method to
repair a spontaneously ruptured amniotic sac.
The introduction of a human fibrin tissue sea-
lant opens a possibility promising at least a
certain measure of success.
The first attempts at sealing tissues date back
to 1944 when CRONKITE [5] and TIDRICK [21]
fixed skin grafts with human fibrin to wound
area. Thirty years later the technique was reviv-
ed and perfected by MATRAS and KUDERNA [18]
who reported on successful neuroanastomosing
in humans by the use of fibrin sealant in 1975.
Mainly for its hemostyptic and adhesive effect,
the two-component fibrin sealant is being used
more and more often in human medicine.
GENZ [7] was the first to report on the possibili-
ty of sealing amniotic leaks. In the meantime
FETTIG [6], ANGER [1], and LUDWIG [17] favored
this technique. KURZ and HUGH [15], in a small
series attempted amniotic sealings, and re-
ported only failures. The different opinions as
to the role of the sealant in the closure of
amniotic leaks may explain the search for the
appropriate method for attaining this goal.
GENZ believes that the real sealing of the amni-
otic leak is brought about by improved adhe-
sion of the chorion to the decidua after fibrin
application. At the same time, the fibrin clot
should act as a barrier between uterus and
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vagina to prevent ascending infection, thus af-
fording protection from AIS. Closure of the
cervical canal itself is not to be expected, as
tissue sealants cannot bridge the gap between
epithelia. GENZ [7 — 12] reported 19 cases be-
tween 1979 and 1982 with a success rate of
60%, which caused us to carry out investiga-
tions with the human fibrin sealant TtesucoL®.
We will report on 26 cases in this paper.
2 Material and methods
In 26 women between gestational weeks 18 and
36, fibrin adhesion was attempted. In all these
cases treatment was because of the mother's
v
 stated desire to have the child despite insuffi-
cient maturity of the fetal lungs. To determine
this insufficiency the following 4 parameters
were used: delta O. D. 650, creatinine determi-
nation, count of orange-stained cells, and ratio
determination.
• r
The principle of closing amniotic leaks is as
follows:
By the application of a fibrin clot, the leakage
of amniotic fluid is interrupted, thus promoting
regeneration of chorion and amnion and their
close contact with the decidua. Direct closure
of the ruptured membranes is not attained.
The fibrinogen solution is clotted by thrombin
(500IU/ml). The fibrin clot is stabilized by
polymerization of fibrin monomers as in the
second stage of blood coagulation; fibrinolysis
is inhibited by the addition of proteinase inhibi-
tors.
From the literature and preliminary trials, we
had gained the impression that no or only an
insufficient fibrin clot is formed when the cer-
vical canal is open, as the clot is flushed out
prematurely by the flow of amniotic fluid. Ac-
cordingly, before applying the sealant, we place
a cerclage by the reverse MCÜONALD procedure
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Figure 1. Modified cerclage technique (reverse MCDONALD procedure).
J. Perinat. Med. 14 (1986)
Baumgarten et al., Fibrin adhesion for PROM 45
which was first published by the author in 1965
[2]. This technique has the advantage that after
minor anterior colpotomy and retraction of the
bladder, a double thread can be wound around
the cervix at the level of the internal os uteri
thus keeping trauma to the cervix to a mini-
mum. Passing the needle and thread parallel to
the tunica vaginalis, a single inward and out-
ward stitch is inserted and then the thread is
turned 360° around the cervix (figure 1). At the
onset of labor the pressure of the thread on the
isthmus uteri is evenly distributed in contrast to
the MCDONALD technique in which the thread
exerts a saw-like effect and prematurely cuts
through the tissue (figure 1).
To apply TTSSUCOL® we routinely use the DUPLO-
JECT double syringe clip (figure 2). This method
has the advantage that the two sealant compo-
nents are contained in separate syringes which
are operated simultaneously. Equal volumes of
both components are mixed in the y-shaped
joining piece before being ejected. A short blunt
needle is attached to the joining piece which,
after dilatation of the external os uteri using 4
pairs of Allis forceps, can be introduced
through the loop encircling the cervix behind
which the fibrin clot is applied without trauma
to the external os uteri. In this way extremely
long and pronounced elevation of the pelvis is
no longer necessary and the patient can be
returned to her bed after 3 minutes.
As direct adhesion of the fibrin sealant to the
cervical wall is not to be expected, we consider
cerclage before application of the fibrin clot to
be essential in order to keep the flow of amniot-
ic fluid to a minimum. The sealant mixture
ejected from the syringe clip results in a clot
which remains in place for at least 10 days.
This was reported by GENZ in 1980 [8] following
his in vitro experiments which we can fully
corroborate. Initially, TISSUCOL® application was
repeated as soon as amniotic fluid was again
seen to escape, despite successful sealing; for
this repeated sealing procedure no anesthesia
was necessary. The anterior and posterior labia
of the os uteri were grasped and separated with
2 pairs of Allis forceps, and 1 ml TISSUCOL® was
applied using the DUPLOJECT syringe clip. If
after 24 hours from the first sealing, the
patient's sanitary napkin was not completely
dry, another sealing was performed and repeat-
ed up to 6 times. At present, we apply the
sealant 3 times at intervals of 24 hours.
Figure 2. Duploject double syringe for application of
fibrin sealant. One syringe contains fibrinogen solution,
the other thrombin combination.
3 Results
Figure 3 demonstrates the prolongation of
pregnancy after the first application of sealant.
Each column represents a single case; the black
colums represent patients whose infants were
alive at birth or survived the first week of life;
the shaded columns represent infants who died
in utero or within the first week of life. It is
evident from this table that most patients (i. e.
13) were first treated between the 26th and the
end of the 33th week of pregnancy and also
that during this period of gestation the fewest
fetal losses occurred. The pregnancy which was
prolonged most continued for more than 172
days after the first application of sealant, the
shortest for just 3 days after attempting to seal
the amniotic leak.
Figure 4 comprises the birth weights of neo-
nates after T^SSUCOL® sealing, irrespective of the
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Figure 3. Prolongation of pregnancy after first application of sealant.
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Figure 4. Birth weights of neonates after TissucOL® sea-
ling, irrespective of the duration of pregnancy from the
time of the first sealant application.
duration of pregnancy at the time of the first
sealant application. Of these 26 pregnancies 17
infants survived. Nine infants died (1 having a
birth weight of 1,680 g, and 1 of 2,240 g).
All the other infants who died had birth weights
of less than 820 g, 4 of them below 400 g.
Surprisingly, none of the surviving children de-
veloped RDS. A single child died post partum
from the sequelae of RDS; this was a breech
presentation weighing l,650g due to severe
placental insufficiency who was delivered by
cesarean section in the 32nd week of pregnancy.
Cortisone was administered intravenously to
all women when it become evident that the
pregnancy could not be prolonged. Parturition
was postponed for at least 12 hours by massive
tocolytic treatment. Twentyfive infants were de-
livered spontaneously, and 3 were delivered by
cesarean section.
4 Discussion
Although a few in vitro experiments have been
performed, [7] the mechanism of action of the
fibrin clot in premature rupture of the mem-
branes is not yet fully understood. Closure of
the spontaneously ruptured arnniotic mem-
branes cannot be achieved with certainty, nor
can this be expected since the leak can hardly
ever be located when blind sealing of the lower
amniotic pole is attempted. Critically speaking,
we cannot claim that in our group of 26 patients
TISSUCOL® sealing has been successful, as long
as no criteria for the evaluation of success or
J. Perinat. Med. 14 (1986)
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failure of such intervention have been agreed
upon. Due to the fact that 17 alive or surviving
children were born of 26 patients, a success rate
of 65% was achieved. GENZ [9 — 12] reported
similar results. Since the whole series of sealings
were performed beyond the 32nd week of preg-
nancy, the question arises as to whether these
were sufficiently justified because the survival
rate in hospitals with optimal neonatal care will
by no means be lower providing the patients
had received tocolytic treatment as long as pos-
sible. It has been observed that rupture of the
membranes prior to the 28th week is linked
with a perinatal mortality of 50%, and we have
registered 5 infants who survived and just as
many who died among our patients in whom
rupture of the membranes occurred between
the 16th and the 28th week. This makes us
question the observation of GENZ that sealing
of the amniotic membranes in the 1st trimester
or the 1st half of the second trimester of preg-
nancy is most successful.
Our results do not confirm this assertion, and
the total number of cases from all publications
is too small to permit definite conclusions.
Possibly, the period by which pregnancy is pro-
longed after the first sealing is the best criterion
of success. When a minimum period of 28 days
is considered as a successful prolongation of
pregnancy, this period has been considerably
exeeded in 6 of our 26 cases, and all 6 patients
had live and surviving infants. If from our
patients all cases are excluded who were treated
with TftssucoL® after the 32nd week, there are
6 successful prolongations as opposed to 11
failures in the remaining patients. This would
be a success rate of 35%, whatever this figure
may mean.
Amniotic infection syndrome was not observed
in any of our cases. None of our patients had
temperatures of more than 37.5 °C in pregnan-
cy or labor, nor did positive HBS antigen or
antibody findings occur within 6 months after
the last sealant application. With respect to a
possible hepatitis hazard, the author will report
elsewhere on a study of 100 cases receiving
TISSUCOL treatment in obstetrics and gynecolo-
gy (BAUMGARTEN, in preparation). In all cases
in whom labor started prematurely in spite of
TISSUCOL® sealing after premature rupture of the
membranes, betamimetic agents were given for
massive intravenous tocolysis without oral
longterm therapy.
The manner in which the TISSUCOL® clot seals a
leaking amniotic sac is completely unknown.
Admittedly, our case number is small, the at-
tempt to close prematurely ruptured mem-
branes by fibrin adhesion appears justified in
view of the lack of complications of the treat-
ment for mother and child and in view of the 17
live and surviving infants in our study. Further
investigations will be necessary to clarify in
which period of pregnancy such attempts are
likely to yield good results.
Summary
The description of a new technique for fibrin adhesion
(in 28 patients) for premature rupture of the membranes
in pregnancy is reported. Unless cerclage has been carri-
ed out earlier, it is necessary to suture the cervical canal
immediately after rupture of the membranes in order to
be able to insert a fibrin clot. The author's modified
cerclage technique (reverse MCÜONALD procedure) is
described. The advantages are minimal trauma to the
lower uterine segment and a somewhat physiologic fixa-
tion of the synthetic suture material. For application of
the fibrin sealant, the DUPLOJECT syringe clip is used, as
it allows exact dosage and blending of the two sealant
components in the course of their application to the site
of sealing.
The problem of evaluation of the results of the procedure
is discussed. The technique carries no risk to mother or
child. No cases of amniotic infection syndrome have
been observed. Through prolongation of the pregnancy,
time is gained for maturation of the fetal lungs. Accord-
ingly, the authors recommend the technique for treating
premature rupture of the membranes, although there is
as yet no definite answer as to the optimal timing of
this adhesion treatment during pregnancy.
Keywords: Amniotic fluid, cerclage techniques, fibrin adhesion, premature labor, premature rupture of membranes.
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Zusammenfassung
Die Technik der Fibrinklebung bei vorzeitigem Blasensp-
rung während der Schwangerschaft
Anhand von 28 Fällen versuchen wir die Brauchbarkeit
eines humanen Fibrinklebers zum Verschluß des unteren
Blasenpoles bei vorzeitigem Blasensprung zu untersu-
chen. Bevor ein Gramm TftssucoL® in der Höhe des unte-
ren Blasenpoles appliziert wird, wird eine Cerclage vor-
angestellt. Die hierfür verwendete Technik entspricht
einer eigenen Modifikation, die „umgekehrte McDo-
NALD Technik" genannt wird. Sie wird im Detail be-
schrieben und hat den Vorteil, daß bei nur einmaligem
Ein- und Ausstechen der Druck des Fadens überall in
der Höhe des innerern Muttermundes gleich stark ist
und ein Durchschneiden dadurch weitgehend verhindert
wird. Für die Applikation des Fibrinklebers wird die
DupLOJECT-Spritze verwandt, da sie genaue Dosierung
und Durchmischung der Kleberkomponenten am Appli-
kationsort gewährleistet.
Über den Wirkungsmechanismus des humanen Gewebs-
klebers bei dieser Art der Behandlung wird diskutiert.
Die Technik birgt keine Risiken für Mutter oder Kind.
Früchtwasserinfektionen wurden nicht beobachtet.
Durch die Schwangerschaftsverlängerung wird Zeit für
die fetale Lungenreifung gewonnen. Aufgrund der Er-
gebnisse kommen wir zum Schluß, daß die Methode im
zweiten Drittel der Schwangerschaft wert ist, versucht
zu werden. Bei vorzeitigem Blasensprung jenseits der 28.
Woche sind die Ergebnisse nicht zufriedenstellend.
Schlüsselwörter: Cerclage, drohende Frühgeburt, Fruchtwasser, Gewebskleber, vorzeitiger Blasensprung.
Resume
Technique de l'adherence de fibrine lors de la rupture
prematuree des membranes au cours de la grossesse
Les auteurs rapportent une nouvelle technique d'adhe-
rence de fibrine chez 28 patientes avec une rupture
precoce des membranes au cours de la grossesse. II est
necessaire d'effectuer un cerclage immediatement apres
la rupture des membranes afin de pouvoir appliquer un
caillot de fibrine, ä moins que ce cerclage ait ete deja
effectue auparavant. Les auteurs decrivent leur techni-
que modifiee du cerclage (technique inverse de MACDO-
NALD); cette technique presente l'avantage d'entramer
un traumatisme minime du segment inferieur et de per-
mettre une fixation plus physiologique du materiel synt-
hetique de suture. On utilise la seringue DUPLOJECT pour
l'application du bouchon de fibrine, ce qui permet uri
dosage precis et un ecoulement a dequat des 2 compo-
sants pendant leur application sur le site d'obturation.
Le probleme de revaluation des resultats du procede est
discute. La technique n'entraine pas de risque pour la
mere ou Fenfant, il n'a pas ete observe de cas d'infection
amniotique et, grace a la prolongation de la grossesse,
on gagne du temps pour la maturation pulmonaire foeta-
le; c'est pourquoi les auteurs recommendent cette techni-
que pour traiter la rupture prematuree des membranes,
bien qu'il n'y ait pas encore de reponse precise concer-
nant le timing optimal du traitement par adherence au
cours de la grossesse.
Mots-cles: Accouchement premature, adherence de fibrine, liquide amniotique, rupture prematuree des membranes,
techniques du cerclage.
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